InMode Ltd. (INMD)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Dec 27, 2024

$17.02

P/E Ratio

9.15

Market Cap

$1.44B

Description

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Metrics

Overview

  • HQYokneam, TA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerINMD
  • Price$17.02-1.62%

Trading Information

  • Market cap$1.44B
  • Float88.44%
  • Average Daily Volume (1m)864,840
  • Average Daily Volume (3m)1,100,896
  • EPS$1.88

Company

  • Revenue$423.75M
  • Rev growth (1yr)5.78%
  • Net income$50.99M
  • Gross margin81.53%
  • EBITDA margin37.16%
  • EBITDA$48.40M
  • EV$651.82M
  • EV/Revenue1.54
  • P/E9.15
  • P/S3.15
  • P/B1.95
Documents